Exagen, Inc. (XGN)
2.95
+0.01
(+0.34%)
USD |
NASDAQ |
May 08, 16:00
2.96
+0.01
(+0.34%)
After-Hours: 20:00
Exagen Shareholders Equity (Quarterly) : 17.45M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Veracyte, Inc. | 1.344B |
| Insight Molecular Diagnostics, Inc. | -31.46M |
| bioAffinity Technologies, Inc. | 3.661M |
| GRAIL, Inc. | 2.501B |
| FONAR Corp. | 176.93M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.20M |
| Total Liabilities (Quarterly) | 41.75M |
| Debt to Equity Ratio | 1.586 |
| Current Ratio | 3.453 |
| Net Debt Paydown Yield | -0.59% |